Skip to content

The Effects of Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) on Pain and Upper Limb Function in Post-Stroke Shoulder-Hand Syndrome: A Randomized Controlled Trial

The Effects of Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) on Pain and Upper Limb Function in Post-Stroke Shoulder-Hand Syndrome: A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600118416
Enrollment
Unknown
Registered
2026-02-05
Start date
2026-02-24
Completion date
Unknown
Last updated
2026-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Interventions

RAVANS group:Using a respiratory-gated percutaneous auricular vagus nerve stimulator (Shenzhen Future Brain Technology Co., Ltd.) placed on the patients left cymba conchae, the stimulation site was wi
the intervention cycle was 20 minutes per session, once daily, five times a week, for a duration of 2 weeks.
taVNS group:A conventional percutaneous auricular vagus nerve stimulator (Shenzhen Future Brain Rate Technology Co., Ltd.) was placed on the cavum conchae of the patients left ear. Before stimulation,
Sham stimulation group:A conventional percutaneous auricular vagus nerve stimulator (Shenzhen Future Brain Rate Technology Co., Ltd.) was applied to the patients left cymba conchae. The stimulation si

Sponsors

Guangdong Provincial Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Meets the diagnostic criteria for stroke and has been clearly diagnosed as a first-onset case through cranial CT or MRI; 2. Meets the diagnostic criteria for post-stroke SHS; 3. Shoulder or hand pain score >= 3; 4. Aged 18-80 years, any gender; 5. Condition is stable, disease duration < 6 months; 6. Signed informed consent form.

Exclusion criteria

Exclusion criteria: 1. Individuals with severe cognitive impairment, aphasia, or inability to cooperate with treatment; 2. Pain caused by other reasons, such as periarthritis of the shoulder, rheumatoid arthritis, etc.; 3. Use of analgesic medications, including oral or injectable forms; 4. Patients with severe cardiovascular or cerebrovascular diseases and organic diseases.

Design outcomes

Primary

MeasureTime frame
Short-form McGill Pain Questionnaire;Upper limb motor function;

Secondary

MeasureTime frame
Physiology;fNIRS brain functional connectivity;Quality of life;Sleep and Emotions;

Countries

China

Contacts

Public ContactWu Cunshu

Guangdong Provincial Hospital of Traditional Chinese Medicine

wcs13829004692@126.com+86 138 2900 4692

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 15, 2026